Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Balance at beginning of period (in shares) at Dec. 25, 2020		59,217,000
Balance at beginning of period at Dec. 25, 2020	$ 617,739	$ 592	$ 659,093	$ (43,018)	$ 756	$ 316
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,036)			(6,014)		(22)
Foreign currency translation adjustments	(52)				(52)
Equity-based compensation	1,060		1,060
Balance at end of period (in shares) at Mar. 26, 2021		59,217,000
Balance at end of period at Mar. 26, 2021	612,711	$ 592	660,153	(49,032)	704	294
Balance at beginning of period (in shares) at Dec. 25, 2020		59,217,000
Balance at beginning of period at Dec. 25, 2020	617,739	$ 592	659,093	(43,018)	756	316
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,092)
Foreign currency translation adjustments	(20)
Balance at end of period (in shares) at Jun. 25, 2021		59,217,000
Balance at end of period at Jun. 25, 2021	622,890	$ 592	671,356	(50,076)	736	282
Balance at beginning of period (in shares) at Mar. 26, 2021		59,217,000
Balance at beginning of period at Mar. 26, 2021	612,711	$ 592	660,153	(49,032)	704	294
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity contributions	10,025		10,025
Net loss	(1,056)			(1,044)		(12)
Foreign currency translation adjustments	32				32
Equity-based compensation	1,178		1,178
Balance at end of period (in shares) at Jun. 25, 2021		59,217,000
Balance at end of period at Jun. 25, 2021	$ 622,890	$ 592	671,356	(50,076)	736	282
Balance at beginning of period (in shares) at Dec. 31, 2021	74,427,000	74,427,000
Balance at beginning of period at Dec. 31, 2021	$ 748,275	$ 744	826,718	(79,420)	(28)	261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,256)			(2,236)		(20)
Foreign currency translation adjustments	6				6
Equity-based compensation	5,599		5,599
Issuance of common stock pursuant to equity incentive plans (in shares)		53,000
Issuance of common stock pursuant to equity incentive plans	0	$ 1	(1)
Balance at end of period (in shares) at Apr. 01, 2022		74,480,000
Balance at end of period at Apr. 01, 2022	$ 751,624	$ 745	832,316	(81,656)	(22)	241
Balance at beginning of period (in shares) at Dec. 31, 2021	74,427,000	74,427,000
Balance at beginning of period at Dec. 31, 2021	$ 748,275	$ 744	826,718	(79,420)	(28)	261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,600)
Foreign currency translation adjustments	$ (2,102)
Balance at end of period (in shares) at Jul. 01, 2022	74,613,000	74,613,000
Balance at end of period at Jul. 01, 2022	$ 753,892	$ 746	838,035	(82,983)	(2,130)	224
Balance at beginning of period (in shares) at Apr. 01, 2022		74,480,000
Balance at beginning of period at Apr. 01, 2022	751,624	$ 745	832,316	(81,656)	(22)	241
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,344)			(1,327)		(17)
Foreign currency translation adjustments	(2,108)				(2,108)
Equity-based compensation	6,768		6,768
Repurchase and retirement of common stock (in shares)		(94,000)
Repurchase and retirement of common stock	(1,048)	$ (1)	(1,047)
Issuance of common stock pursuant to equity incentive plans (in shares)		227,000
Issuance of common stock pursuant to equity incentive plans	$ 0	$ 2	(2)
Balance at end of period (in shares) at Jul. 01, 2022	74,613,000	74,613,000
Balance at end of period at Jul. 01, 2022	$ 753,892	$ 746	$ 838,035	$ (82,983)	$ (2,130)	$ 224